bioRxiv · 10.64898/2026.03.13.711570
ISG15-USP18 signaling restrains viperin-dependent metabolic antiviral restriction
Abstract
Type I interferon (IFN-I) responses are tightly regulated to balance antiviral defense with cellular homeostasis. In humans, interferon-stimulated gene 15 (ISG15) functions as a critical negative regulator of IFN-I signaling by stabilizing the IFN negative regulator USP18, yet the functional consequences of ISG15 deficiency remain elusive. Here, we show that the loss of ISG15 exaggerates the JAK-STAT activation and, downstream, amplifies multiple ISGs including the nucleotide-modifying enzyme RSAD2 (viperin). Our quantitative proteomics, genetic reconstitution, and signaling analyses establish that defective USP18 stabilization skews the IFN response towards viperin expression. This amplified ISG network promotes viperin-catalyzed accumulation of the antiviral nucleotide analog ddhCTP, resulting in enhanced inhibition of viral RNA synthesis and the replication of Crimean-Congo hemorrhagic fever virus and SARS-CoV-2. Together, these findings demonstrate an ISG15-USP18-viperin axis that can be targeted to boost the metabolic antiviral restriction.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Kahler, N. L., Rezene, S., Scholte, F. E., Ambikan, A. T., Saccon, E., Monteil, V., Naval, P., Macmillan, R., Frick, S., Noren, J., Lourda, M., Mirazimi, A., Bryceson, Y. T., Lira-Junior, R., Prasad, V., Vegvari, A., Neogi, U., Bamford, C., Hofer, A., Bergeron, E., Purhonen, J., Gupta, S.. 2026-03-14. ISG15-USP18 signaling restrains viperin-dependent metabolic antiviral restriction. https://doi.org/10.64898/2026.03.13.711570
Cite the original work for its findings. Save a collection to share your selection of sources.